Epitalon Research Overview: A Four-Letter Peptide From the Pineal Literature

Epitalon is a tiny peptide with a big reputation online. Strip away the chatter and you get something simpler: four amino acids, a handful of cell and mouse studies, and a 2025 review that says the mechanism is still open. This epitalon research overview walks through the literature the way we would want it explained to us. Where it came from. What was tested. Where the evidence stops. And what a lot certificate should show before a vial goes on a lab bench.

Where epitalon came from

The story starts with an extract, not a peptide. Epithalamin is a preparation taken from the bovine pineal gland. Researchers at the St. Petersburg Institute of Bioregulation and Gerontology, led by Vladimir Khavinson, studied it for years. They then designed a synthetic tetrapeptide modeled on the amino acid composition of that extract. The result was Ala-Glu-Asp-Gly, written AEDG for short. That is epitalon.

You will also see it spelled Epithalon. Same molecule. The spelling shifts between papers and between suppliers, so we list both. The extract (epithalamin) and the synthetic peptide (epitalon) are different things, and the literature does not always keep them apart. Human data published for the pineal extract, for example, do not tell you anything about the synthetic tetrapeptide. When you read an epitalon claim, check which one the underlying study actually used.

The four epitalon research areas

The published work clusters into four themes. Here is each one in plain words.

Telomerase activity in cultured cells

This is the paper most people have heard of. Khavinson et al., 2003 added epitalon to cultures of human fetal fibroblasts. The cells were reported to show telomerase activity and longer telomeres. It is one cell-culture study, from the originating group. The Araj et al., 2025 review notes that the mechanism behind this remains uncertain. So the honest summary is: an interesting in vitro result, not a settled mechanism.

Lifespan and tumour incidence in mice

Anisimov et al., 2003 followed female Swiss-derived SHR mice over their lives. Mean lifespan did not change. The oldest animals, the last ten percent to survive, lived longer in the treated group. The paper also tracked biomarkers of aging and spontaneous tumours. It is a single-strain, single-sex mouse study, and the authors are from the same research network. That context matters when reading the headline.

Pineal and melatonin-related work

Because the parent extract came from the pineal gland, several studies looked at pineal function and melatonin. Reviews describe reported effects on melatonin synthesis and on several enzymes. The same reviews are careful to say it is unclear whether those effects explain anything else epitalon has been reported to do. We think that caution is the right note to end on here.

Antioxidant activity in laboratory models

The fourth theme is antioxidant activity measured in laboratory systems. These are bench assays and animal tissue measurements, not outcomes in people. They sit alongside the other three areas as part of the preclinical picture.

What the 2025 overview adds

For a long time the epitalon literature was scattered across Russian-language journals and a few English papers. The Araj et al., 2025 overview in the International Journal of Molecular Sciences pulls it together. Its authors describe in vitro, in vivo and in silico (computer modelling) work. Their conclusion on mechanism is plain: it is not established. For a research buyer, that is useful. It tells you the questions are still open, which is exactly what makes a compound worth studying.

Research status: mostly preclinical

Here is where epitalon sits today, as the literature reports it.

• Most evidence is in cultured cells and rodents.
• One mouse study found no change in mean lifespan but longer survival of the oldest animals.
• Controlled human trials are lacking. We found no registered trial and no FDA-approved product.
• Much of the work comes from a single research group in St. Petersburg.

None of this makes epitalon less interesting. It just means claims about what it does in people are ahead of the data. We keep our language on the shelf to match.

Epitalon and its cousins

Epitalon belongs to a family of very short peptides often called bioregulators. The family includes Pinealon (Glu-Asp-Arg), Vesugen (Lys-Glu-Asp), Vilon (Lys-Glu) and Testagen (Lys-Glu-Asp-Gly). Note how close Testagen is to epitalon: swap the first alanine for a lysine and you have it. These peptides share a research origin and a research style. They are not interchangeable, and each has its own small literature. If you are comparing them, our bioregulator peptides guide covers the rest of the family.

Lot testing for a four-residue peptide

A short peptide is easy to describe and still worth testing properly. Here is what we look for on an epitalon lot before it is listed.

• Identity by mass spectrometry. A tetrapeptide has a small, exact mass. MS confirms the vial contains a molecule of that mass. It does not confirm the order of the residues on its own, which is why the sequence is fixed at synthesis and checked against the synthesis record.
• Purity by HPLC. The chromatogram separates the main peak from related impurities, such as truncated sequences or leftover protecting groups. Each lot's certificate states its measured purity and identity. We do not print a blanket number, because the figure belongs to the lot, not the product page.
• Appearance and fill. A white to off-white lyophilised powder, with the fill weight stated on the label and on the certificate.

The certificate of analysis for each lot is linked from the product page. If a lot has no certificate, it is not listed.

Storage

Epitalon is supplied as a lyophilised powder in a crimp-sealed glass vial with a flip-top cap. Store at -20 °C, desiccated. Keep it sealed until it is needed on the bench. Short peptides are robust compared with long ones, but moisture and repeated warming still shorten shelf life.

Quick spec

Item	Detail
Name	Epitalon (Epithalon)
Sequence	Ala-Glu-Asp-Gly (AEDG)
Type	Synthetic tetrapeptide
Origin	Modeled on bovine pineal extract (epithalamin)
Research stage	Mostly preclinical
Format	10 mg lyophilised powder, glass vial
House code	PTY-EPI-10
Storage	-20 °C, desiccated
Documentation	Per-lot certificate with HPLC and MS

Frequently asked questions

Is epitalon the same as epithalamin?

No. Epithalamin is an extract from the bovine pineal gland. Epitalon is a synthetic four-amino-acid peptide designed from the amino acid composition of that extract. Studies of one do not stand in for studies of the other.

What did the epitalon mouse study find?

In female SHR mice, Anisimov et al., 2003 reported no change in mean lifespan. The longest-lived animals survived longer in the treated group. It is one study in one strain, and the authors were from the originating research network.

Has epitalon been tested in controlled human trials?

Not that we could find. The published evidence is largely in vitro and in rodents. No registered trial or FDA-approved product turned up in our search.

Why does a tetrapeptide still need an HPLC trace?

Mass spectrometry confirms the mass. HPLC shows how much of the vial is the main peak and how much is related impurities. Both appear on each lot's certificate, together with the measured purity and identity.

See it in the catalogue: Epitalon.